Enhancement For Play For Men
Natural health product licensed in Canada
- Licence holder
- Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
- NPN or DIN-HM
- 80036207
- Status
- Active licence
- Licence date
- 5 October 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Extrait de Feuille Extraction ratio : 50:1 Dry plant equivalent : 1,250 mg Potency : 24 % flavone glycosides | 25 mg | Not calculated |
| Ginkgo biloba Source : Extrait de Feuille Potency : 6 % terpene lactones | Not specified | Not calculated |
| Panax ginseng Source : Root (standardized extract) Extraction ratio : 4:1 Dry plant equivalent : 252 mg Potency : 10 % ginsenosides | 63 mg | Not calculated |
| Lepidium meyenii Source : Extrait de racine Extraction ratio : 5:1 Dry plant equivalent : 1,500 mg | 300 mg | Not calculated |
| Cistanche deserticola Source : Plante(s) entière | 25.5 mg | Not calculated |
| Curcuma longa Source : Rhizome | 49 mg | Not calculated |
| Epimedium brevicornum Source : Parties aériennes | 25.5 mg | Not calculated |
| Rhodiola rosea Source : Extrait de racine Extraction ratio : 6:1 Dry plant equivalent : 270 mg Potency : 3 % salidrocides | 45 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, cellulose, Extrait de pellicule de raisin
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in herbal medicine to help enhance physical capacity/performance. Helps to support emotional aspects of sexual health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80036207
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.